GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HSF2 | hg19_v2_chr6_+_122720681_122720713 | -0.15 | 2.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_75931861 Show fit | 28.81 |
ENST00000248553.6
|
heat shock 27kDa protein 1 |
|
chr12_+_69979210 Show fit | 19.59 |
ENST00000544368.2
|
chaperonin containing TCP1, subunit 2 (beta) |
|
chr12_+_69979113 Show fit | 16.05 |
ENST00000299300.6
|
chaperonin containing TCP1, subunit 2 (beta) |
|
chr12_+_69979446 Show fit | 15.13 |
ENST00000543146.2
|
chaperonin containing TCP1, subunit 2 (beta) |
|
chr18_+_3449695 Show fit | 14.54 |
ENST00000343820.5
|
TGFB-induced factor homeobox 1 |
|
chr9_+_33025209 Show fit | 13.96 |
ENST00000330899.4
ENST00000544625.1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
chr2_+_198365122 Show fit | 13.54 |
ENST00000604458.1
|
HSPE1-MOB4 readthrough |
|
chr18_-_812231 Show fit | 13.19 |
ENST00000314574.4
|
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |
|
chr18_+_3449821 Show fit | 12.92 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGFB-induced factor homeobox 1 |
|
chr11_+_65770227 Show fit | 12.20 |
ENST00000527348.1
|
barrier to autointegration factor 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.9 | 50.8 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.1 | 35.2 | GO:0042493 | response to drug(GO:0042493) |
2.5 | 29.5 | GO:0015074 | DNA integration(GO:0015074) |
1.0 | 29.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
7.2 | 28.8 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
2.1 | 24.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
2.4 | 19.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.4 | 19.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 16.0 | GO:0007498 | mesoderm development(GO:0007498) |
0.4 | 13.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 58.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 38.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 37.1 | GO:0044429 | mitochondrial part(GO:0044429) |
0.1 | 31.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.9 | 29.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.6 | 28.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 23.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 20.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
2.0 | 14.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 13.2 | GO:0005884 | actin filament(GO:0005884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 61.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.7 | 48.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 30.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.8 | 30.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 29.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
9.6 | 28.8 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
1.6 | 16.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 13.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 13.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 12.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 53.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 28.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 19.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 17.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 17.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 14.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 14.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 12.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 7.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.6 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 61.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.0 | 48.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.5 | 41.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
3.3 | 29.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 20.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 16.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 15.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.7 | 13.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 10.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 9.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |